QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 medical-properties-trust-approves-150m-stock-repurchase-program

 - SEC Filing

 medical-properties-trust-q3-ffo-013-misses-015-estimate-sales-237522m-beat-233548m-estimate

Medical Properties Trust (NYSE:MPW) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate ...

 wells-fargo-maintains-underweight-on-medical-properties-trust-lowers-price-target-to-45

Wells Fargo analyst John Kilichowski maintains Medical Properties Trust (NYSE:MPW) with a Underweight and lowers the price t...

 medical-properties-trust-q2-ffo-014-inline-sales-240359m-beat-233492m-estimate

Medical Properties Trust (NYSE:MPW) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. Th...

 rbc-capital-maintains-sector-perform-on-medical-properties-trust-lowers-price-target-to-45

RBC Capital analyst Michael Carroll maintains Medical Properties Trust (NYSE:MPW) with a Sector Perform and lowers the price...

 medical-properties-trust-q1-ffo-014-misses-015-estimate-sales-22380m-miss-22981m-estimate

Medical Properties Trust (NYSE:MPW) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate ...

 exane-bnp-paribas-upgrades-medical-properties-trust-to-outperform-raises-price-target-to-9

Exane BNP Paribas analyst Nate Crossett upgrades Medical Properties Trust (NYSE:MPW) from Neutral to Outperform and raises t...

 rbc-capital-maintains-sector-perform-on-medical-properties-trust-raises-price-target-to-5

RBC Capital analyst Michael Carroll maintains Medical Properties Trust (NYSE:MPW) with a Sector Perform and raises the price...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION